Töötajad

Tagasi

  • Kontakt

    Piret Veerus

    Vanemteadur

    Telefon:
    659 3946
    E-post:
    piret.veerus@tai.ee
    Osakond:
    Epidemioloogia ja biostatistika osakond

Haridus ja eriala

  • Tampere Ülikooli arstiteaduskond, PhD, cum laude
  • Tartu Ülikool, ravi eriala, MD, cum laude

Teaduskraadi info

Doktorikraad (PhD), 2007, "The impact of postmenopausal hormone therapy on health and use of health services: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial" (e.k "Menopausijärgse hormoonravi mõju tervisele ja tervishoiuteenuste kasutamisele: uuringu "Üleminekuiga ja naiste tervis kogemus"), Tampere Ülikool, arstiteaduskond

Teadustegevuse põhisuunad

Rahvatervis, naiste tervis ja vähi sõeluuringud

Käimasolevad projektid

  • Vähi sõeluuringute registri loomise projektijuht (alates mai 2012)
  • "Üleminekuiga ja naiste tervis – hormoonasendusravi postmenopausis", koostöös Soome tervise ja heaolu instituudiga (THL)

Valitud publikatsioonid

  • Veerus P, Lexchin J, Hemminki E. Legislative regulation and ethical governance of medical research in different European Union countries. J Med Ethics. 2013 May 10. [Epub ahead of print]
  • Maver PJ, Seme K, Korać T, Dimitrov G, Döbrőssy L, Engele L, Iljazović E, Kesić V, Kostova P, Laušević D, Maurina A, Nicula FA, Panayotova Y, Primic Žakelj M, Repše Fokter A, Romejko-Wolniewicz E, Smailytė G, Şuteu O, Świderska-Kiec J, Tachezy R, Valerianova Z, Veerus P, Vīberga I, Znaor A, Zubor P, Poljak M. Cervical cancer screening practices in central and eastern Europe in 2012. Acta Dermatovenerol Alp Panonica Adriat. 2013;22(1):7-19
  • Kirss F, Lang K, Toompere K, Veerus P. Prevalence and risk factors of urinary incontinence among Estonian postmenopausal women. Springerplus. 2013 Oct 17;2:524
  • Veerus P, Hovi SL, Sevón T, Hunter M, Hemminki E. The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial. BMC Res Notes. 2012;5:176. doi: 10.1186/1756-0500-5-176
  • Veerus P, Fischer K, Hakama M, Hemminki E; EPHT Trial. Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial. BMC Med Res Methodol. 2012;12:44. doi: 10.1186/1471-2288-12-44
  • Baili P, Hoekstra-Weebers J, Van Hoof E, Bartsch HH, Travado L, Garami M, Di Salvo F, Micheli A, Veerus P; The EUROCHIP-3 Working group on Cancer Rehabilitation. Cancer rehabilitation indicators for Europe. Eur J Cancer. 2012 Dec 10. doi:pii: S0959-8049(12)00862-3. 10.1016/j.ejca.2012.10.028. [Epub ahead of print]
  • Hemminki E, Regushevskaya E, Luoto R, Veerus P. Variability of bothersome menopausal symptoms over time - a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT).BMC Womens Health. 2012;12:44. doi: 10.1186/1472-6874-12-44.
  • Kivistik A, Lang K, Baili P, Anttila A, Veerus P. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. BMC Womens Health. 2011;11:43
  • Anttila A, Arbyn M, Veerus P, Viberga I, Kurtinaitiene R, Valerianova Z, Apostol I, Baili P, Micheli A. Barriers in cervical cancer screening programs in new European Union member states. Tumori 2010; 96:515-6
  • Anttila A, Ronco G; Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009;45:2685-708
  • Ronco G, Ballegooijen MV, Becker N, Chil A, Fender M, Giubilato P, Kurtinaitis J, Lancucki L, Lynge E, Morais A, O'Reilly M, Sparen P, Suteu O, Rebolj M, Veerus P, Zakelj MP, Anttila A. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009;45:2659-70
  • Hemminki E, Veerus P, Pisarev H, Hovi SL, Topo P, Karro H. The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - experience from the EPHT trial. BMC Women’s Health 2009;9:16
  • Veerus P, Fischer K, Hovi SL, Karro H, Rahu M, Hemminki E. Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial. BMC Women's Health 2008;8:5
  • Hovi SL, Veerus P, Rahu M, Hemminki E. Experiences of a long-term randomized controlled prevention trial in a maiden environment: Estonian Postmenopausal Hormone Therapy trial. BMC Med Res Methodol 2008; 8:51
  • Veerus P, Fischer K, Hovi SL, Karro H, Hemminki E. Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. BJOG 2007;114:548-54
  • Veerus P, Hovi SL, Fischer K, Rahu M, Hakama M, Hemminki E. Results from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial [ISRCTN35338757]. Maturitas 2006;55:162-73
  • Veerus P, Fischer K, Hovi SL, Hakama M, Rahu M, Hemminki E. Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. Am J Obstet Gynecol 2006;195:62-71
  • Hovi SL, Hakama M, Veerus P, Rahu M, Hemminki E. Who wants to join preventive trials? – Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. BMC Med Res Methodol 2005;5:12
  • Hovi SL, Veerus P, Karro H, Topo P, Hemminki E. Women's views of climacteric at the time of low menopausal hormone use, Estonia 1998. Maturitas 2005;51:413-25
  • Vorobjov S, Hovi SL, Veerus P, Pisarev H, Rahu M, Hemminki E. Treatment adherence in the Estonian Postmenopausal Hormone Therapy (EPHT) Trial [ISRCTN35338757]. Maturitas 2005;52:286-95

Publikatsioonide loetelu Eesti Teadusportaalis 

Liikmelisus

1990 -  Eesti Arstide Liit, liige
1991 -  Eesti Naistearstide Selts, juhatuse liige

CV Eesti Teadusportaalis